Abstract Fragment-based screening can catalyze drug discovery by identifying novel scaffolds. but this approach is limited by the small chemical libraries studied by biophysical experiments and the challenging optimization process. To expand the explored chemical space. we employ structure-based docking to evaluate orders-of-magnitude larger libraries than those used in traditional fr... https://www.roneverhart.com/L-Homme-Ideal-Cologne-by-Guerlain/